Health Catalyst price target raised to $10 from $8 at Evercore ISI

Evercore ISI raised the firm’s price target on Health Catalyst to $10 from $8 and keeps an Outperform rating on the shares. The firm is adjusting estimates and making additions to Evercore’s “Tactical Outperform” and “Tactical Underperform” lists ahead of Q3 earnings from the Healthcare Technology and Distribution group.